journal cover

Amiodarone - a 'broad spectrum' antiarrhythmic drug

Cardiovascular & Hematological Disorders Drug Targets

Jan 1, 2010

Sujeeth R PunnamRanjan K Thakur

Abstract

Amiodarone, an iodinated benzofuran derivative, introduced in 1960's as an anti-anginal agent, emerged as a potent anti-arrhythmic agent by 1970's and is currently one of the most commonly prescribed drugs in US for ventricular and atrial arrhythmias. Although amiodarone is considered a...read more

Mentioned in this Paper

Lung
Coronary Artery Disease
Macrolide Antibiotics
Amiodarone
Cytochrome P450
Ventricular Dysfunction, Left
Amiodarone hydrochloride
Digoxin
Anti-Arrhythmia Agents
Warfarin
Paper Details
References
  • References
  • Citations11
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations11
12

Similar Papers Found In These Feeds

Coronary Artery Disease

Coronary artery disease is extremely prevalent in western societies and is the number one cause of morbidity and mortality industrialized countries. Known risk factors include hypertension, smoking and dyslipidemia. Discover the latest research on coronary artery disease here.

Heart Rhythm & Arrythmias

Heart arrhythmias, also known as irregular heartbeat or cardiac dysrhythmia, are a group of conditions where the heartbeat is irregular (dysrhythmia), too slow (bradycardia), or too fast (tachycardia). Discover the latest research on heart rhythm and arrythmias here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

HFrEF

Heart failure with reduced ejection fraction (HF-rEF) is responsible for high costs and increased rates of hospital admissions along with high mortality and morbidity risks. Only treatment for HF-rEF has been shown to be efficacious compared to HF-pEF which currently has no useful treatment options. Here is the latest research on HF-rEF.

Inotropic Agents & Heart Disease

Inotropic agents alter the force or energy of muscular contractions. Negatively inotropic agents weaken the force of muscular contractions. Positively inotropic agents increase the strength of muscular contraction. Inotropic agents are used in hospitalized patients with acute decompensated heart failure, with reduced left ventricular ejection fraction and with signs of end-organ dysfunction in the setting of a low cardiac output, or with severe systolic heart failure awaiting heart transplant to maintain hemodynamic stability or as a bridge to decision. Discover the latest research on inotrpic agents and heart diseases here.

HFpEF

HF-pEF is associated with left ventricular diastolic dysfunction and concentric left ventricular hypertrophy and has significant mortality and morbidity. The heterogeneity of the disease has resulted in the failure of any drugs for the treatment of HF-pEF. Here are the latest discoveries pertaining to this disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Mechanisms of CYP450

Cytochrome P450 (CYP450) are a family of enzymes involved in two major processes, such as the synthesis of fatty acids, steroids, and biles acids, and the metabolism of toxins and drugs. Discover the latest research on the Mechanisms of CYP450 enzymes here.

Coronary Artery Aneurysm

Coronary artery aneurysms are the dilation of the coronary arteries that supply the heart tissue with blood and nutrients. The dilation exceeds 1.5 times the normal artery size. Complications can occur if these aneurysms rupture. Here is the latest research on coronary artery aneurysms.

Related Papers

The New England Journal of Medicine

Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation

The New England Journal of MedicineMarch 22, 2002
Paul DorianAiala Barr
Nature Reviews. Endocrinology

Effects of amiodarone therapy on thyroid function

Nature Reviews. EndocrinologyNovember 26, 2009
Janna Cohen-LehmanIrwin Klein
© 2020 Meta ULC. All rights reserved

Amiodarone - a 'broad spectrum' antiarrhythmic drug

Cardiovascular & Hematological Disorders Drug Targets

Jan 1, 2010

Sujeeth R PunnamRanjan K Thakur

PMID: 20041841

DOI: 10.2174/187152910790780032

Abstract

Amiodarone, an iodinated benzofuran derivative, introduced in 1960's as an anti-anginal agent, emerged as a potent anti-arrhythmic agent by 1970's and is currently one of the most commonly prescribed drugs in US for ventricular and atrial arrhythmias. Although amiodarone is considered a...read more

Mentioned in this Paper

Lung
Coronary Artery Disease
Macrolide Antibiotics
Amiodarone
Cytochrome P450
Ventricular Dysfunction, Left
Amiodarone hydrochloride
Digoxin
Anti-Arrhythmia Agents
Warfarin

Similar Papers Found In These Feeds

Coronary Artery Disease

Coronary artery disease is extremely prevalent in western societies and is the number one cause of morbidity and mortality industrialized countries. Known risk factors include hypertension, smoking and dyslipidemia. Discover the latest research on coronary artery disease here.

Heart Rhythm & Arrythmias

Heart arrhythmias, also known as irregular heartbeat or cardiac dysrhythmia, are a group of conditions where the heartbeat is irregular (dysrhythmia), too slow (bradycardia), or too fast (tachycardia). Discover the latest research on heart rhythm and arrythmias here.

Related Papers

The New England Journal of Medicine

Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation

The New England Journal of MedicineMarch 22, 2002
Paul DorianAiala Barr
Nature Reviews. Endocrinology

Effects of amiodarone therapy on thyroid function

Nature Reviews. EndocrinologyNovember 26, 2009
Janna Cohen-LehmanIrwin Klein
Paper Details
References
  • References
  • Citations11
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations11
12
/papers/amiodarone---a-broad-spectrum-antiarrhythmic/20041841